Dr. Dunchok Grounded: DEA Yanks Controlled Substance License
Published Date: 6/9/2025
Notice
Summary
Dr. Ron Dunchok lost his DEA registration because he no longer has permission to handle controlled substances in California. He didn’t ask for a hearing after being notified, so the DEA moved forward and officially revoked his registration. This means Dr. Dunchok can’t legally prescribe or handle controlled drugs anymore, effective immediately.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Physician
The Drug Enforcement Administration revoked Ron Dunchok, M.D.'s DEA Certificate of Registration No. BD0178081. As of July 9, 2025, he is not authorized to prescribe, dispense, or otherwise handle controlled substances in California.
Pending and New California DEA Applications Denied
The Order denies any pending applications by Ron Dunchok, M.D., to renew or modify Certificate No. BD0178081, and denies any other pending application by him for additional DEA registration in California. This denial is effective July 9, 2025.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-11572 — Ashley Vermillion, N.P.; Decision and Order
Ashley Vermillion, a nurse practitioner from Maine, lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing, so the DEA moved forward and officially revoked her registration. This means she can’t prescribe or manage controlled drugs anymore, effective immediately.
2026-11416 — Importer of Controlled Substances Application: CalCog Inc.
CalCog Inc. wants to become an official importer of some powerful controlled substances like LSD and 5-MeO-DMT. People and companies involved with these drugs have until July 8, 2026, to share their thoughts or ask for a hearing. This move could shake up the import scene, but no costs or changes happen until the DEA decides.
2026-10380 — Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
The DEA wants to put diphenidine, a drug, into Schedule I, which means it will be treated like the most tightly controlled substances. This change affects anyone who makes, sells, studies, or owns diphenidine, adding strict rules and penalties. You’ve got until June 25, 2026, to share your thoughts before the new rules might kick in.
2026-10253 — Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
Starting May 22, 2026, the DEA is putting 2-fluorodeschloroketamine (2-FDCK) into Schedule I, meaning it’s now treated like the most dangerous drugs. This affects anyone who makes, sells, or uses it, adding strict rules and serious penalties. The temporary ban lasts two years, giving the government time to decide if it should stay permanent.
Previous / Next Documents
Previous: 2025-09955 — Agency Information Collection Activities: Requests for Comments; Clearance of New Approval of Information Collection: Expedited Special Government Interest (SGI) Waiver or Authorization for Unmanned Aerial Systems (UAS) Operations
The FAA wants your feedback on a new form that helps drone pilots get quick permission to fly in restricted areas during emergencies. This affects drone operators involved in important missions like firefighting, search and rescue, and law enforcement. The public has 60 days to comment, and this new process aims to speed up approvals without extra costs.
Next: 2025-10365 — United States-Mexico-Canada Agreement (USMCA), Article 10.12: Binational Panel Review: Notice of Request for Panel Review
A review panel was asked to check the U.S. decision on large welded pipe from Canada, following a five-year antidumping review. This affects pipe makers and importers by potentially changing trade rules or costs. The request was officially filed on May 30, 2025, with a case number assigned, so everyone’s watching the clock for updates and possible money impacts.